The content on this site is intended for healthcare professionals only
Conferences
ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
EACR 2012
7 - 10 Jul 2012
Molecular stratification of breast cancer: reaching the clinic
Prof Carlos Caldas - University of Cambridge, UK
25 Jul 2012
Circulating metastasis-initiating cells in breast cancer
Prof Andreas Trumpp - German Cancer Research Centre (DKFZ), Heidelberg, Germany
19 Jul 2012
The ceRNA Hypothesis and the non-coding revolution in cancer research and therap...
Prof Pier Paolo Pandolfi - Harvard Medical School, Boston, USA
19 Jul 2012
Epithelial mesenchyme transition in cancer cells
Prof Jean-Paul Thiery – Institute of Molecular and Cell Biology, Singapore
18 Jul 2012
Australia Pancreatic Cancer Genome Initiative
Dr Marina Pajic – The Garvan Institute of Medical Research, Darlinghurst, Austra...
18 Jul 2012
Underlying metabolic pathways in cancer
Dr Arkaitz Carracedo – Ikerbasque, Bilbao, Spain
18 Jul 2012
Potential for micro-RNA based cancer treatments
Prof Carlo Croce – Ohio State University, Columbus, USA
18 Jul 2012
Understanding the mechanisms of breast cancer resistance
Prof Jos Jonkers – Netherlands Cancer Institute, Amsterdam, Netherlands
18 Jul 2012
Translational and tailored, but can we afford it?
Prof Gordon McVie - European Institute of Oncology and ecancer
17 Jul 2012
Translational and tailored, but can we afford it?
Prof Ulrik Ringborg - Karolinska Institute, Stockholm, Sweden
17 Jul 2012
Cost efficiency of targeted therapy
Dr Maria Grazia Daidone - Foundazione IRCCS Istituto Nazionale dei Tumori, Italy
17 Jul 2012
Society and money - the cancer conundrum
Prof Richard Sullivan – Kings College, London, UK
17 Jul 2012
Translating cancer research to personalised treatment: Can it work?
Prof Joan Seoane – Vall d’Hebron Institute of Oncology, Spain
17 Jul 2012
The immuno side of melanoma
Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA
16 Jul 2012
Constructing successful biomarker clinical trials
Dr Lisa McShane – National Cancer Institute, Bethesda, USA
16 Jul 2012
Highlights of the 22nd EACR meeting and tackling glioblastoma
Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain
16 Jul 2012
The changing field of drug development
Dr Jonathan Yingling – Oncology Drug Discovery, Eli Lilly
16 Jul 2012
Epigenetics of cancer and changes in DNA modification in tumours
Prof Manel Esteller – University of Barcelona, Catalonia, Spain
16 Jul 2012
